Literature DB >> 29657879

Primary hyperparathyroidism and Gougerot disease.

Toumader Bouziane1, Nadia Belmahi1, Hanan El Ouahabi1,2.   

Abstract

Primary hyperparathyroidism (PHPT) is a common endocrine disorder caused by the overactivation of the parathyroid glands due to the autonomous production of the parathyroid hormone (PTH). The resultant hypercalcemia leads to a myriad of symptoms. Here we report the case of a 54-year-old female with a previous diagnosis of Gougerot disease, in whom clinical (diffuse bone pain, asthenia polydipsia, and polyuria) and laboratory features (calcium level, 3.1 mmol/L; phosphate level, 0.55 mmol/L; alkaline phosphatase level, 70 U/L; and intact PTH level, 1028.9 pmol/L) prompted the diagnosis of PHPT caused by a parathyroid adenoma as confirmed by anatomopathology. After treatment with renal replacement therapy, intravenous fluids and zolendronic acid, and subtotal parathyroidectomy, the patient status improved, with normal laboratory tests. However, the fortuitous nature of the association between Gougerot disease and PHPT as well as the physiopathological links between these two diseases remain to be specified.

Entities:  

Keywords:  Gougerot disease; hypercalcemia; parathyroid hormone; primary hyperparathyroidism

Year:  2017        PMID: 29657879      PMCID: PMC5895156          DOI: 10.5152/eurjrheum.2017.16127

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  10 in total

1.  Severe hypercalcemia as a presenting sign of systemic lupus erythematosus.

Authors:  Raymond Farah; Rola Farah; Nicola Makhoul
Journal:  Eur J Intern Med       Date:  2006-05       Impact factor: 4.487

Review 2.  Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature.

Authors:  T P Karageorgas; N Avgoustidis; D Ioakeimidis
Journal:  Scand J Rheumatol       Date:  2011-09-15       Impact factor: 3.641

Review 3.  Sjögren's syndrome, the old and the new.

Authors:  Yogev Peri; Nancy Agmon-Levin; Emanuel Theodor; Yehuda Shoenfeld
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

4.  [Pathophysiology of primary Sjögren's syndrome].

Authors:  C Martel; M-O Jauberteau; E Vidal; A-L Fauchais
Journal:  Rev Med Interne       Date:  2014-01-08       Impact factor: 0.728

5.  Hypercalcemia and systemic lupus erythematosus.

Authors:  L J Deftos; D W Burton; S M Baird; R A Terkeltaub
Journal:  Arthritis Rheum       Date:  1996-12

6.  Lymphoedema/hypercalcaemia syndrome mediated by parathyroid-hormone-related protein.

Authors:  S Braude; A Graham; D Mitchell
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

7.  [Etiology and pathogenesis of primary hyperparathyroidism.]

Authors:  Mika Yamauchi; Toshitsugu Sugimoto
Journal:  Clin Calcium       Date:  2017

Review 8.  Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia.

Authors:  J G Erdozain; M V Egurbide; G Ruiz-Irastorza; J Ojanguren; C Aguirre
Journal:  Lupus       Date:  2004       Impact factor: 2.911

Review 9.  Thyroid disease in Sjögren's syndrome.

Authors:  Luis J Jara; Carmen Navarro; María del Pilar Brito-Zerón; Mario García-Carrasco; Ricardo O Escárcega; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2007-06-09       Impact factor: 2.980

10.  Rheumatoid arthritis associated with hypoparathyroidism and Sjögren's syndrome.

Authors:  M E Edmonds; A Saunders; R D Sturrock
Journal:  J R Soc Med       Date:  1979-11       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.